What do systematic reviews say?

Intervention not reported

It is very uncertain whether the intervention changes GP invitation letter versus invitation letter from other authority… (very low certainty).

• Interventions targeted at women to encourage the uptake of cervical screening 2021 · Cochrane Headline outcomes only
  RR 1.69 [0.75, 3.82]
  2 studies · 86 participants
  Very low

Intervention not reported

The intervention may leads to higher personal invitation versus invitation letter: uptake of screening (low certainty).

• Interventions targeted at women to encourage the uptake of cervical screening 2021 · Cochrane Headline outcomes only
  RR 1.32 [1.11, 1.56]
  5 studies · 27663 participants
  Low

Intervention not reported

The intervention probably leads to higher letter with fixed appointment versus letter with open invitation to… (moderate certainty).

• Interventions targeted at women to encourage the uptake of cervical screening 2021 · Cochrane Headline outcomes only
  RR 1.61 [1.48, 1.75]
  5 studies · 5742 participants
  Moderate

Intervention not reported

It is very uncertain whether the intervention changes counselling versus control: uptake of screening (very low certainty).

• Interventions targeted at women to encourage the uptake of cervical screening 2021 · Cochrane Headline outcomes only
  RR 1.23 [1.04, 1.45]
  2 studies · 393 participants
  Very low

Intervention not reported

It is very uncertain whether the intervention changes counselling versus other: uptake of screening (very low certainty).

• Interventions targeted at women to encourage the uptake of cervical screening 2021 · Cochrane Headline outcomes only
  RR 1.13 [0.9, 1.41]
  1 study · 208 participants
  Very low

Intervention not reported

The intervention may leads to higher education versus control: uptake of screening (low certainty).

• Interventions targeted at women to encourage the uptake of cervical screening 2021 · Cochrane Headline outcomes only
  RR 1.35 [1.18, 1.54]
  13 studies · 63415 participants
  Low

Intervention not reported

• Interventions targeted at women to encourage the uptake of cervical screening 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2500 participants
  Very low

Intervention not reported

The review found no eligible studies for this question.

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The intervention leads to higher BEV+IRI (1 RCT, 79 participants) (high certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 2.22 [1.19, 4.18]
  1 study · 79 participants
  High

Intervention not reported

The intervention leads to higher BEV+VB111 (1 RCT, 128 participants) (high certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 3.77 [2.25, 6.33]
  1 study · 111 participants
  High

Intervention not reported

The intervention leads to higher BEV+TRC 105 (1 RCT, 49 participants) (high certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 6.86 [2.55, 18.41]
  1 study · 105 participants
  High

Intervention not reported

The review found no eligible studies for this question.

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 1024 participants
  GRADE not reported

Intervention not reported

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  8 studies · 498 participants
  GRADE not reported

Intervention not reported

The intervention showed no clear difference in FOM (1 RCT, 32 participants); GRADE not reported.

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 0.44 [0.11, 1.72]
  1 study · 32 participants
  GRADE not reported

Intervention not reported

The intervention showed no clear difference in BEV+HSPPC96 1 RCTs; 53 participants) (low certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 1.01 [0.33, 3.1]
  1 study · 96 participants
  Low

Intervention not reported

The intervention showed no clear difference in BEV+ONA(1 RCT; 64 participants) (low certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 1.17 [0.57, 2.39]
  1 study · 64 participants
  Low

Intervention not reported

The intervention showed no clear difference in BEV+CAB (1 RCT; 58 participants) (low certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 1.27 [0.61, 2.66]
  1 study · 58 participants
  Low

Intervention not reported

The intervention showed no clear difference in BEV+DAS (2 RCTs, 83 participants) (high certainty).

• Treatment options for progression or recurrence of glioblastoma: a network meta‐analysis 2021 · Cochrane Headline outcomes only
  RR 0.52 [0.69, 3.34]
  2 studies · 83 participants
  High

Psychosocial intervention to improve sexual health vs no intervention

• Interventions to improve psychosocial well‐being in female BRCA‐mutation carriers following risk‐reducing surgery 2019 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 34 participants
  Very low